Clinical trial
A Study of 5 Fluorouracil and the Anti-Tumor Activity of ADH300004 and 5…
NCT00264472 · Adherex Technologies, Inc., Industry · Suspended
Key facts
| NCT number | NCT00264472 |
|---|---|
| Title | A Study of 5 Fluorouracil and the Anti-Tumor Activity of ADH300004 and 5 Fluorouracil in Subjects With Incurable Solid Tumors |
| Official title | A 2-Part Phase 1 Study Evaluating the Safety and Anti-Tumor Activity of ADH300004 (Eniluracil) Administered With 5-Fluorouracil (5-FU), and the Pharmacokinetics of 5-FU Given as: 5.0 mg ADH300004 With Escalating Doses of 5-FU Administered Orally 3 Weeks Out of 4 in Subjects With Refractory Solid… |
| Lead sponsor | Adherex Technologies, Inc., Industry |
| Status | Suspended |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Neoplasms |
| Intervention type | Drug |
| Interventions | ADH300004 |
| Enrollment | 60 |
| Start date | Jan 1, 2006 |
| Primary completion | Jun 1, 2009 |
| First posted | Dec 13, 2005 |
| Last update posted | Dec 15, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: